Cardiac Pacemakers Market

Cardiac Pacemakers Market (Product Type: Internal and External; and Technology: Dual Chambered, Single Chamber, and Biventricular) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Cardiac Pacemakers Market Outlook 2031

  • The global industry was valued at US$ 4.4 Bn in 2022
  • It is estimated to grow at a CAGR of 3.5% from 2023 to 2031 and reach US$ 5.9 Bn by the end of 2031

Analyst Viewpoint

Rise in demand for minimally invasive surgeries and growth in product authorization by regulatory bodies are key factors augmenting the cardiac pacemakers industry size.

Implantation of cardiac pacemakers is a minimally invasive procedure that helps prevent excessive blood loss and rules out the probability of post-operative complications. Speedy approval for technologically advanced pacemakers by regulatory organizations, such as the U.S. FDA, is also boosting cardiac pacemakers market statistics.

Companies operating in the global cardiac pacemakers market are carrying out advancements in pacemaker systems and technologies to help patients better manage abnormal or slow heartbeat. Key players are following the latest cardiac pacemakers industry trends and incorporating next-generation features in modern cardiac pacemakers to increase their industry share.

Market Introduction

Cardiac pacemakers, also known as cardiac rhythm management devices, are small electrical devices implanted in the chest. They are used in the treatment of certain abnormal heart rhythms (arrhythmias) that lead the heart to miss beats or beat slowly.

Emerging trends in leadless cardiac pacemaker technology include incorporation of pacemaker programming for optimal heart rate control. Such pacemakers utilize built-in sensors to detect a signal that indicates requirement for a quicker heartbeat.

Therefore, sensor stimulations are calculated in compliance with programmed settings for dynamics of response and permitted alterations of change in the pacing rate.

Technological upgrade in electrodes/leads have cut down upon requirements of energy. Starting with nickel-cadmium rechargeable battery (lasting for less than two years), then zinc-mercury battery (lasting for over two years), and later graduating to lithium iodine battery (lasting for over 10 years), these advancements have facilitated a decrease in the overall price of cardiac pacemakers.

Wireless connectivity and remote management of cardiac pacemakers enable both the physician and patient to access automatic test results and complete diagnostics through remote and flexible scheduling. This is accelerating the demand for electrotherapy cardiac devices.

However, there is a likelihood of the development of a blood clot in one of the veins in the arm at the side of the body where the pacemaker is implanted.

Furthermore, pacemaker wires are inserted close to one of the lungs; therefore, there exists a risk of the lung getting punctured during the pacemaker insertion procedure. These are some of the factors hampering the cardiac pacemakers market growth.

Attribute Detail
Drivers
  • Rise in Demand for Minimally Invasive Surgeries
  • Growth in Product Authorization by Regulatory Bodies

Rise in Demand for Minimally Invasive Surgeries Fueling Cardiac Pacemakers Industry

Minimally invasive surgeries result in minimal interruption to the physiology of the patient, which leads to a shorter recovery time. These surgeries are linked to less pain, shorter hospital stays, and fewer complications.

Robotic technology is adopted to carry out certain minimally invasive surgeries, as it allows precise control over the surgery. Other minimally invasive surgeries are performed without robotic assistance.

Repair of heart valves, atrial fibrillation, and mitral valve prolapse are some of the surgeries carried out with the assistance of robotic techniques.

Adoption of minimally invasive heart surgeries is rising across the globe, as these surgeries offer benefits such as less blood loss, reduced pain, shorter hospital stay, less visible scars, and faster recovery. Insertion of a pacemaker is usually performed in a minimally invasive surgical procedure.

Permanent pacemaker insertion is one of the highly adopted minimally invasive implantation techniques. Thus, long-term benefits of cardiac pacing through minimally invasive procedures are fueling the cardiac pacemakers market value.

Growth in Product Authorization by Regulatory Bodies Driving Cardiac Pacemakers Market Demand

The US Food and Drug Administration (FDA) evaluates high-risk medical devices such as cardiac implantable electronic devices (CIEDs), including pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy devices, via the premarket approval process.

Manufacturers need to submit clinical data demonstrating effectiveness and safety of their products. Any changes to these high-risk devices are carried out via ‘supplements,’ which may not require additional clinical testing.

Rise in approval of cardiac pacemakers by regulatory bodies is one of key factors augmenting the cardiac pacemakers market revenue. These approvals give manufacturers a fair chance to provide artificial heart pacing units to a growing pool of patients.

Cardiac pacemakers that are approved by regulatory bodies such as the U.S. FDA and the European Medicines Agency (EMA) are looked upon as the ones meeting high performance and safety standards.

The U.S. FDA approved more than 10 newly devised cardiac pacemakers in 2023. Among them, Abbott’s AVEIR dual chamber leadless pacemaker system was approved by the U.S. FDA in July 2023. Furthermore, in May 2023, Medtronic’s Micra VR2 and Micra AV2 received approval from the U.S. FDA as the next generation leadless, miniaturized pacemaker.

Such emerging trends in leadless cardiac pacemaker technology have paved the way for the development of the first dual chamber and small-sized leadless pacing system.

Regional Outlook

Attribute Detail
Leading Region North America

As per the latest cardiac pacemakers market analysis, North America dominated the industry for implantable heart rate controllers in 2022. The region is likely to maintain its dominant position during the forecast period.

According to the American Heart Association’s report published in January 2019, almost 50% of the American population is suffering from a form of heart disease (including high blood pressure), which may require the implantation of heart pacemakers.

Europe is witnessing a significant increase in demand for artificial cardiac stimulators due to growth in incidence of heart failure, heart arrests, asthma, and cardiac arrhythmias in the region. As per the Eurostat, Germany witnessed around 37,200 heart bypasses in 2021.

Asia Pacific is likely to account for key cardiac pacemakers market share during the forecast period, led by the rise in number of patients contracting cardiac disorders in the region.

Analysis of Key Players in Cardiac Pacemakers Market

Companies operating in the global cardiac pacemakers landscape are focusing upon the development of pacing devices that offer remote patient monitoring. For instance, Medtronic’s Bluetooth-enabled heart devices are able to communicate to the patient’s clinic on direct basis through the MyCareHeart mobile app.

Key players are also investing significantly in technology advancements to introduce smaller and smart devices, increase device longevity, and improve functionality of their devices in order to strengthen their position in the global landscape.

Biotronik, Boston Scientific Corporation, Cook, Medico S.p.A., Medtronic, LivaNova PLC, and Abbott are some of the prominent players profiled in the cardiac pacemakers market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Key Developments

  • In June 2021, India Medtronic Pvt. Ltd. Introduced Micra AV, a self-contained, miniaturized pacemaker delivering advanced pacing technology to atrioventricular (AV) block patients via minimally invasive procedure. The device is the first pacemaker capable of sensing atrial activity without lead in the heart’s upper chamber.
  • In March 2021, Boston Scientific announced the completion of acquisition of Preventice Solutions for US$ 1.2 Bn with the objective of expanding its portfolio with respect to remote monitoring offerings and mobile health solutions

Market Snapshot

Attribute Detail
Market Size in 2022 US$ 4.4 Bn
Market Forecast (Value) in 2031 US$ 5.9 Bn
Growth Rate (CAGR) 3.5%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value and Units for Volume
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product Type
    • Internal
    • External
  • Technology
    • Dual Chambered
    • Single Chambered
    • Biventricular
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • Biotronik
  • Boston Scientific Corporation
  • Cook
  • Medico S.p.A.
  • Medtronic
  • LivaNova PLC
  • Abbott
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global cardiac pacemakers market in 2022?

It was valued at US$ 4.4 Bn in 2022

How is the cardiac pacemakers business expected to grow during the forecast period?

It is projected to grow at a CAGR of 3.5% from 2023 to 2031

What are the key factors driving the demand for cardiac pacemakers?

Rise in demand for minimally invasive surgeries and growth in product authorization by regulatory bodies

Which cardiac pacemakers’ product type segment held the largest share in 2022?

The internal segment accounted for the largest share in 2022

Which region dominated the global cardiac pacemakers landscape in 2022?

North America was the dominant region in 2022

Who are the key cardiac pacemaker manufacturers?

Biotronik, Boston Scientific Corporation, Cook, Medico S.p.A, Medtronic, LivaNova PLC, and Abbott

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Cardiac Pacemakers Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Cardiac Pacemakers Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Cardiac Pacemakers Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Internal

            6.3.2. External

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global Cardiac Pacemakers Market Analysis and Forecast, by Technology

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Technology, 2017–2031

            7.3.1. Dual Chambered

            7.3.2. Single Chambered

            7.3.3. Biventricular

        7.4. Market Attractiveness Analysis, by Technology

    8. Global Cardiac Pacemakers Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region, 2017–2031

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Region

    9. North America Cardiac Pacemakers Market Analysis and Forecast

        9.1. Introduction

        9.2. Key Findings

        9.3. Market Value Forecast, by Product Type, 2017–2031

            9.3.1. Internal

            9.3.2. External

        9.4. Market Value Forecast, by Technology, 2017–2031

            9.4.1. Dual Chambered

            9.4.2. Single Chambered

            9.4.3. Biventricular

        9.5. Market Value Forecast, by Country, 2017–2031

            9.5.1. U.S.

            9.5.2. Canada

        9.6. Market Attractiveness Analysis

            9.6.1. By Product Type

            9.6.2. By Technology

            9.6.3. By Country

    10. Europe Cardiac Pacemakers Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Product Type, 2017–2031

            10.3.1. Internal

            10.3.2. External

        10.4. Market Value Forecast, by Technology, 2017–2031

            10.4.1. Dual Chambered

            10.4.2. Single Chambered

            10.4.3. Biventricular

        10.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            10.5.1. Germany

            10.5.2. U.K.

            10.5.3. France

            10.5.4. Italy

            10.5.5. Spain

            10.5.6. Rest of Europe

        10.6. Market Attractiveness Analysis

            10.6.1. By Product Type

            10.6.2. By Technology

            10.6.3. By Country/Sub-region

    11. Asia Pacific Cardiac Pacemakers Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Product Type, 2017–2031

            11.3.1. Internal

            11.3.2. External

        11.4. Market Value Forecast, by Technology, 2017–2031

            11.4.1. Dual Chambered

            11.4.2. Single Chambered

            11.4.3. Biventricular

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. China

            11.5.2. Japan

            11.5.3. India

            11.5.4. Australia & New Zealand

            11.5.5. Rest of Asia Pacific

        11.6. Market Attractiveness Analysis

            11.6.1. By Product Type

            11.6.2. By Technology

            11.6.3. By Country/Sub-region

    12. Latin America Cardiac Pacemakers Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Product Type, 2017–2031

            12.3.1. Internal

            12.3.2. External

        12.4. Market Value Forecast, by Technology, 2017–2031

            12.4.1. Dual Chambered

            12.4.2. Single Chambered

            12.4.3. Biventricular

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. Brazil

            12.5.2. Mexico

            12.5.3. Rest of Latin America

        12.6. Market Attractiveness Analysis

            12.6.1. By Product Type

            12.6.2. By Technology

            12.6.3. By Country/Sub-region

    13. Middle East & Africa Cardiac Pacemakers Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Product Type, 2017–2031

            13.3.1. Internal

            13.3.2. External

        13.4. Market Value Forecast, by Technology, 2017–2031

            13.4.1. Dual Chambered

            13.4.2. Single Chambered

            13.4.3. Biventricular

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. GCC Countries

            13.5.2. South Africa

            13.5.3. Rest of Middle East & Africa

        13.6. Market Attractiveness Analysis

            13.6.1. By Product Type

            13.6.2. By Technology

            13.6.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        14.2. Market Share Analysis, by Company (2022)

        14.3. Company Profiles

            14.3.1. Biotronik

                14.3.1.1. Company Overview

                14.3.1.2. Product Portfolio

                14.3.1.3. SWOT Analysis

                14.3.1.4. Financial Overview

                14.3.1.5. Strategic Overview

            14.3.2. Boston Scientific Corporation

                14.3.2.1. Company Overview

                14.3.2.2. Product Portfolio

                14.3.2.3. SWOT Analysis

                14.3.2.4. Financial Overview

                14.3.2.5. Strategic Overview

            14.3.3. Cook

                14.3.3.1. Company Overview

                14.3.3.2. Product Portfolio

                14.3.3.3. SWOT Analysis

                14.3.3.4. Financial Overview

                14.3.3.5. Strategic Overview

            14.3.4. Medico S.p.A.

                14.3.4.1. Company Overview

                14.3.4.2. Product Portfolio

                14.3.4.3. SWOT Analysis

                14.3.4.4. Financial Overview

                14.3.4.5. Strategic Overview

            14.3.5. Medtronic

                14.3.5.1. Company Overview

                14.3.5.2. Product Portfolio

                14.3.5.3. SWOT Analysis

                14.3.5.4. Financial Overview

                14.3.5.5. Strategic Overview

            14.3.6. LivaNova PLC

                14.3.6.1. Company Overview

                14.3.6.2. Product Portfolio

                14.3.6.3. SWOT Analysis

                14.3.6.4. Financial Overview

                14.3.6.5. Strategic Overview

            14.3.7. Abbott

                14.3.7.1. Company Overview

                14.3.7.2. Product Portfolio

                14.3.7.3. SWOT Analysis

                14.3.7.4. Financial Overview

                14.3.7.5. Strategic Overview

    List of Tables

    Table 01: Global Cardiac Pacemakers Market Value (US$ Mn) and Volume (Number of Number of Units) Forecast, by Product Type, 2017–2031

    Table 02: Global Cardiac Pacemakers Market Volume (Number of Units) Forecast, by Product Type, 2017–2031

    Table 03: Global Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Technology, 2017–2031

    Table 04: Global Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 06: North America Cardiac Pacemakers Market Volume (Number of Units) Forecast, by Product Type, 2017–2031

    Table 07: North America Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Technology, 2017–2031

    Table 08: North America Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 09: Europe Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 10: Europe Cardiac Pacemakers Market Volume (Number of Units) Forecast, by Product Type, 2017–2031

    Table 11: Europe Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Technology, 2017–2031

    Table 12: Europe Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 13: Asia Pacific Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 14: Asia Pacific Cardiac Pacemakers Market Volume (Number of Units) Forecast, by Product Type, 2017–2031

    Table 15: Asia Pacific Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Technology, 2017–2031

    Table 16: Asia Pacific Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Latin America Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 18: Latin America Cardiac Pacemakers Market Volume (Number of Units) Forecast, by Product Type, 2017–2031

    Table 19: Latin America Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Technology, 2017–2031

    Table 20: Latin America Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 21: Middle East & Africa Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 22: Middle East & Africa Cardiac Pacemakers Market Volume (Number of Units) Forecast, by Product Type, 2017–2031

    Table 23: Middle East & Africa Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Technology, 2017–2031

    Table 24: Middle East & Africa Cardiac Pacemakers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure 01: Global Cardiac Pacemakers Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

    Figure 02: Global Cardiac Pacemakers Market Revenue (US$ Mn), by Product Type, 2022

    Figure 03: Global Cardiac Pacemakers Market Value Share, by Product Type, 2022

    Figure 04: Global Cardiac Pacemakers Market Revenue (US$ Mn), by Technology, 2022

    Figure 05: Global Cardiac Pacemakers Market Value Share, by Technology, 2022

    Figure 06: Global Cardiac Pacemakers Market Value Share, by Region, 2022

    Figure 07: Global Cardiac Pacemakers Market Value (US$ Mn) Forecast, 2023–2031

    Figure 08: Global Cardiac Pacemakers Market Value Share Analysis, by Product Type, 2022–2031

    Figure 09: Global Cardiac Pacemakers Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 10: Global Cardiac Pacemakers Market Value Share Analysis, by Technology, 2022–2031

    Figure 11: Global Cardiac Pacemakers Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 12: Global Cardiac Pacemakers Market Value Share Analysis, by Region, 2022–2031

    Figure 13: Global Cardiac Pacemakers Market Attractiveness Analysis, by Region, 2023–2031

    Figure 14: North America Cardiac Pacemakers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 15: North America Cardiac Pacemakers Market Attractiveness Analysis, by Country, 2023–2031

    Figure 16: North America Cardiac Pacemakers Market Value Share Analysis, by Country, 2022–2031

    Figure 17: North America Cardiac Pacemakers Market Value Share Analysis, by Product Type, 2022–2031

    Figure 18: North America Cardiac Pacemakers Market Value Share Analysis, by Technology, 2022–2031

    Figure 19: North America Cardiac Pacemakers Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 20: North America Cardiac Pacemakers Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 21: Europe Cardiac Pacemakers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 22: Europe Cardiac Pacemakers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 23: Europe Cardiac Pacemakers Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 24: Europe Cardiac Pacemakers Market Value Share Analysis, by Product Type, 2022–2031

    Figure 25: Europe Cardiac Pacemakers Market Value Share Analysis, by Technology, 2022–2031

    Figure 26: Europe Cardiac Pacemakers Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 27: Europe Cardiac Pacemakers Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 28: Asia Pacific Cardiac Pacemakers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 29: Asia Pacific Cardiac Pacemakers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 30: Asia Pacific Cardiac Pacemakers Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 31: Asia Pacific Cardiac Pacemakers Market Value Share Analysis, by Product Type, 2022–2031

    Figure 32: Asia Pacific Cardiac Pacemakers Market Value Share Analysis, by Technology, 2022–2031

    Figure 33: Asia Pacific Cardiac Pacemakers Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 34: Asia Pacific Cardiac Pacemakers Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 35: Latin America Cardiac Pacemakers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 36: Latin America Cardiac Pacemakers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 37: Latin America Cardiac Pacemakers Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 38: Latin America Cardiac Pacemakers Market Value Share Analysis, by Product Type, 2022–2031

    Figure 39: Latin America Cardiac Pacemakers Market Value Share Analysis, by Technology, 2022–2031

    Figure 40: Latin America Cardiac Pacemakers Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 41: Latin America Cardiac Pacemakers Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 42: Middle East & Africa Cardiac Pacemakers Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 43: Middle East & Africa Cardiac Pacemakers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 44: Middle East & Africa Cardiac Pacemakers Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 45: Middle East & Africa Cardiac Pacemakers Market Value Share Analysis, by Product Type, 2022–2031

    Figure 46: Middle East & Africa Cardiac Pacemakers Market Value Share Analysis, by Technology, 2022–2031

    Figure 47: Middle East & Africa Cardiac Pacemakers Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 48: Middle East & Africa Cardiac Pacemakers Market Attractiveness Analysis, by Technology, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved